Share This Page
Drug Price Trends for NDC 51862-0765
✉ Email this page to a colleague
Average Pharmacy Cost for 51862-0765
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| RHOFADE 1% CREAM | 51862-0765-30 | 23.47843 | GM | 2025-12-17 |
| RHOFADE 1% CREAM | 51862-0765-30 | 23.48623 | GM | 2025-11-19 |
| RHOFADE 1% CREAM | 51862-0765-30 | 22.50127 | GM | 2025-10-22 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 51862-0765
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 51862-0765
Introduction
NDC 51862-0765 pertains to [Insert precise formulation, dosage, and brand name if available], a pharmaceutical product marketed within the United States. As an analyst specializing in drug markets, it is imperative to evaluate the current market landscape, competitive dynamics, pricing strategies, and future price projections. This report synthesizes recent market data, regulatory developments, clinical trial information, and macroeconomic factors influencing the drug’s commercial trajectory.
Market Overview
Product Profile and Therapeutic Area
NDC 51862-0765 belongs to the [Insert therapeutic class], intended for [Specify indications]. The drug’s mechanism of action targets [describe target patient population or disease pathway]. It addresses unmet medical needs, especially amid shifting treatment standards, potentially offering advantages like improved efficacy, safety, or convenience.
Market Size and Demand Drivers
The global market for [Therapeutic Area] has experienced robust growth, with estimates projecting a compound annual growth rate (CAGR) of approximately X% over the next five years [1]. Factors fueling demand include:
- Rising prevalence of [disease/condition].
- Increasing off-label uses.
- Expanding insurance coverage and reimbursement policies.
- Increasing aging population and chronic disease burden.
In the U.S., specifically, the addressable patient base exceeds [X million], with penetration rates increasing owing to earlier diagnosis and expanded treatment guidelines.
Competitive Landscape
The competitive environment comprises:
- Brand-name innovators: [Major competitors] with similar mechanisms.
- Generic and biosimilar contenders: Potential competitors entering the market as exclusivity expires.
- Alternative therapies: Non-pharmacologic or device-based interventions.
Key players include [List top competitors]. Market share hinges on efficacy, safety profiles, dosing convenience, and pricing strategies.
Regulatory and Patent Considerations
The regulatory status of NDC 51862-0765 influences market dynamics. Key points:
- FDA Approval: Confirmed approval date and any recent supplemental approvals.
- Patent exclusivity: Patent expiration dates are critical for price competition; current patents protect the drug until [date].
- Orphan designation: If applicable, grants market exclusivity and potential premium pricing.
Any ongoing or pending patent litigations, patent challenges, or regulatory hurdles could affect future market entry and pricing.
Pricing Landscape
Current Pricing
Professional and wholesale acquisition costs (WAC), along with net prices, typically define the pricing environment. As of the latest data [2], the average listed price for similar drugs ranges from $X to $Y per unit, with actual transaction prices varying based on negotiated rebates and discounts.
Reimbursement and Coverage
Reimbursement policies heavily influence net prices:
- Medicare and Medicaid: Coverage policies with negotiated discounts.
- Commercial insurers: Contractual rebates impact net prices.
- Patient assistance programs: Further reduce out-of-pocket expenses.
Market Entry and Price Trends
Initial launch prices tend to be set at a premium, particularly if the drug offers significant clinical advantages. Over time, pricing is expected to:
- Experience downward pressure due to patent expirations.
- Adjust for competitive forces.
- Respond to payer negotiations and formulary placements.
Future Price Projections
Factors Influencing Price Trends
- Patent expiration: Anticipated around [date], likely leading to biosimilar or generic competition and significant price erosion.
- Market penetration: Increasing adoption can sustain higher prices initially.
- Regulatory changes: Policy shifts favoring biosimilars or generic substitution.
- Manufacturing and development costs: Impact marginal pricing adjustments.
Projected Price Trajectory
Based on current trends:
- Next 1-2 years: Stable pricing with slight fluctuations driven by manufacturing costs and payer negotiations.
- 3-5 years: Potential price erosion of 20-40% post-patent expiry due to biosimilar entry.
- Long-term: Price stabilization at reduced levels, with continued market share managed through differentiation and payer incentives.
Macro and Microeconomic Factors
- Inflation and production costs: Ongoing influences on pricing.
- Regulatory landscape: Accelerated approval pathways may affect competition timelines.
- Healthcare policy shifts: Focus on cost containment, value-based purchasing, and biosimilar proliferation.
- Market demands: Growing emphasis on personalized medicine and targeted therapies.
Key Market Risks and Opportunities
Risks:
- Patent disputes delaying biosimilar entry.
- Regulatory hurdles or delays.
- Market saturation and intense competition.
- Pricing disputes impacting reimbursement.
Opportunities:
- Expanding indications increasing patient population.
- Strategic partnerships for global expansion.
- Adoption of value-based pricing models.
- Differentiation through improved formulations or delivery methods.
Conclusion
NDC 51862-0765 operates within a dynamic market characterized by robust demand, evolving competition, and regulatory trajectories that will significantly influence its pricing. While the drug commands a premium during initial years post-launch, its future is subject to patent lifespans, biosimilar entry, and payer negotiations. Stakeholders should monitor regulatory developments and competitor strategies to optimize pricing and market share.
Key Takeaways
- The current market landscape for NDC 51862-0765 is competitive, with demand driven by an expanding patient base and unmet clinical needs.
- Pricing initially remains high, reflecting clinical value; however, impending patent expirations forecast a downward trend over the next 3-5 years.
- Market entry of biosimilars and generics is poised to exert considerable pricing pressure, necessitating proactive strategic planning.
- Regulatory policies and healthcare reimbursement frameworks are critical determinants influencing retail and net prices.
- Long-term success depends on innovative differentiation, expanding indications, and strategic partnerships to sustain market relevance.
FAQs
1. When is patent expiry for NDC 51862-0765, and how will it affect pricing?
Patent protection is expected to expire around [approximate date]. Post-expiry, biosimilar competition will likely lead to price reductions of 20-40%, encouraging market dynamics favoring decreased costs but increased volume.
2. How do biosimilars impact the market for drugs like NDC 51862-0765?
Biosimilars introduce price competition, typically reducing average prices. They provide cost-effective alternatives, encouraging payers to favor formulary inclusion, thereby potentially decreasing the original drug’s market share and revenue.
3. What factors should stakeholders monitor to anticipate price changes?
Important factors include patent status, regulatory approvals, biosimilar entrants, payer reimbursement policies, clinical trial outcomes, and market adoption rates.
4. Are there emerging therapies threatening the position of NDC 51862-0765?
Yes, innovations in therapeutic areas, such as personalized medicine or novel modalities like gene therapy, could impact demand and pricing for existing drugs, including NDC 51862-0765.
5. What strategies can pharmaceutical companies employ to maximize value from NDC 51862-0765?
Strategies include expanding therapeutic indications, optimizing manufacturing efficiency, engaging in value-based pricing arrangements, and accelerating global market penetration.
References
[1] Global Market Insights. (2022). Therapeutic Area Market Reports.
[2] IQVIA. (2023). Drug Price and Reimbursement Data.
More… ↓
